Director of Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Andersen Eric, buys 56,490 shares worth $206,189
According to Merrimack Pharmaceuticals Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 16 04:05 PM, company Director, Andersen Eric disclosed buying 56,490 shares at a cost of $3.65. At the time of this transaction (Nov 12), this trade was worth $206,189 in total. As of Nov 12, Andersen Eric now owns 822,014 shares in total worth about $3,041,451.8000000003.
For the last few recent trades made by Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Director, Andersen Eric, we have the following information:
- SEC Form 4 filing: Aug 13: Bought 609 shares at the rate of $3.50 per share. Total worth of this trade was $2,132. Total number of shares owned as of Aug 13 were 820,055
- SEC Form 4 filing: Aug 11: Bought 14,030 shares at the rate of $3.45 per share. Total worth of this trade was $48,437. Total number of shares owned as of Aug 11 were 241,212
- SEC Form 4 filing: Aug 12: Bought 2,000 shares at the rate of $3.49 per share. Total worth of this trade was $6,986. Total number of shares owned as of Aug 12 were 243,212
Posted by
George Daniels
on Monday November 16 2020, 5:28 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
